throbber
I9, Number 2
`
`February 2002
`
`PHREEB |9(2) |l5—2I6 (2002)
`ISSN 0724-874!
`
`An Official journal of the American Association
`of Pharmaceutical Scientists
`
`
`
`Cancer Pharmacology
`Thermophysical Properties
`Drug Targeting
`Computational Biopharmaceutics
`
`9) mm
`
`In This Issue:
`
`NERACADEMICl
`
`iUM PUBLISHERS
`
`Page 1 of 11
`
`CSL EXHIBIT 1059
`
`Page 1 of 11
`
`CSL EXHIBIT 1059
`
`

`

`
`
`
`.
`
`
`
`-
`
`..
`
`PHARMACEUTICAL RESEARCH
`An Ollie-M Journal of the American ASSOCIIIIIOII of Pharmaceutical Scientists
`-
`l'hunnun-imtnl Rcu'urth publishes innuialive basic research and leehnulogiml advances in [he phuiniateulital-binnitdicnl WIK‘IICL‘F. RIM-Juli .ircas
`inumzil melude‘ phunnueculiu and dru}I delivery. pharmucnkinctiu iind phiirmnecidynnmies. drug metabolism. pliannaeI-lugi iind ltNltultigy‘ medicinal g
`Ii;iliiral products chcinNI). analytical eliemisll}. chemical kinelio and diug stabllil) . biulechnulug}. phiiniiiiceutical technology. and clinical investigat .
`as articles on lhc want eennnmic. ui management aspects nt lhc pharmaceutical wicnecs
`EIII'I'OIl-lN-CHIEF
`Keaidti lnli. Kyutu l'nivcrsil)‘ Hmpilal. Kit-Iii. Japan
`Vince-I H. L. Lee. Deplirtmenl nil PhllrmJCL'UIIClll Ken-mes. lll'liu‘hlh ul
`MyI-n K. Jacobson. L‘nitcniiy tit Ariznnn. Tiiemn. Arvnna
`Southem (‘nlil'nrnm. Ins Angeles. California
`Rudy L. Jolene. University Ill North (‘umlinu ill (‘hupcl Hill.
`North ('Juilina
`EDITOR—EUROPE
`Telwyl Kamila“. Hokkaido l"fll\'L‘l!~ll\ Jiipiin
`Dun ('rn-melin. I'Ircchi I‘nnersil). l‘lrcehI Hi: Vclhfllldnd\
`Mitts 0. Klrlsmn. l'ppmla L nt\clsll}. l ppuilu. Sweden
`EDITOR—JAPAN
`Kwnng-J'm Kiln. Univemh nl Southern ('alilornia. LIN Angela. 0
`String Wen Kim. llnnersil) lil l'llih. Still Luke Cil). l'luh
`Milm "I‘llldl, Kym-i l'mtersu), Kintn Lipan
`Tmltiltim Klmun. Okayama l nucml). Okayama. Japan
`ASSOCIATE EDITORS
`AnV. Ton) Kong, Ringers—The Shite l'nii'enitt nl New Jersey.
`Khum Purl. l'urdue liniiemily. \Vcil lalaiene. lnllinnn
`New Jersey
`Dnvld E. SIIlIII. lv'liii‘eisiti nl' Mieliigun. Anti Aihui. Miehipnii
`Jintlridt Kopeeek. llniierm) nl l'l.ih. '\'all Lake ('il_\x I'lali
`ASSOCIATE EDITORS—EUROPE
`Darin Kroetr. llrin ers'il) ul ('iililnmin. Sim l:l;II1CINCt). Californi-
`Peter R. Luggltli. lulunnes (nulenheig-l‘mwmli. Mainl. (it:
`I
`Meladert Dlnhol. Leiden Uniwrsil). Leiden. 111i: Netherlands
`(‘Iii-Ho Lee. l‘us‘an \dlinniil University Pusan. Snuth Knrea
`load 1. I'nldler. llirechi I'nnemly. Utrecht
`l‘he Nelherlumh
`m Chitin Lee. bung Ki utiLwnii Universin Simon (’ili. South
`EDITORIAL ADVISORY BOARD
`Set-lg .liri Lee. thwu Wiimcns Unnersin. Seoul, South Knrca
`Mull Jose Aloiun. Liniwrsiiy nl Sziiitiupn dc (‘IimpIMeL-i. (hnlptlh Slll’. Spnin
`Chas-Mlduel Leh. l'ni'i‘ersily l‘l Saurland. Suurhruecken. Ge .
`“mum ‘1. Lndden. (iltihuMnx l.l.(‘. llamwer. Mainland
`Gunilla L. Amidon. l'lIlVL'lSIl} of Michigan. Ann Arbor. Michigan
`Bridle) Andenou. l'nueml) ul Kentucky. leunginn KunlueLy
`Krhfim Lmlinua. Cunt-hing l’nnersily. Sweden
`Per Artumn. l'ppstila l‘niversil). l'ppxailli. Sncden
`Pimm Mather-s. Univeml) at Athens. Alhens. (truce:
`Jennie L-S. AI. ()liui Sliitc l nl\’t.'l.\lly. ("Illumhus. Uhiu
`Rlnthll l. Mun). ( iirtltll l, niwnil)‘. (Sarditl. lfmled Kingdom
`You-Hui Bk. Kunngdu ln~lilule ul Science tk 'leehnnlug), Rhine-Iii.
`Tod-nod MaytIln‘i. ()xnkn l'nii-ersity. OsrikiL annn
`\nulh Knren
`1m} R. Nedelmln. Nuurlii l‘linrnimeulimls, [Lual llanui :1. New
`l‘eter Bonnie. lLLx ()neulugi Sun Amt-Inn. lexnu
`Derek T. O'Hngen. ("himn rfllptlrlllllln. chrWIlle_ California
`Ron-Id T. Ron-lint“. Uniiemiy nl Kansas, Lawrence. Rum-us
`Fermi OIL-no. 1 UK)" Women‘s Medical t'ullege. lukyu. Lipan
`Michael J. Piltnl. Ijniivrsili ul (‘nnneclieuL Slur“. ('nnnet‘lieul
`lulu.- lIonstrl. Leidanmslt-rduni (mm In! Diug Rewnreli. lhe
`Nelherlnntk
`Mull I’niusniu. Georgia Institute u!
`ICL’hIltIlt)g\ Georgia
`Harry Britt-in. ( enter Iiir Pharmaceutical Physics. Mill'uld. New Jersey
`Mm Rellinn. St. Jude Children's Research limpilnl. Memphis. T
`Kim L. R. Bmtrwer. l'mvemtv at North ( urnlma Ell ('hiipcl lllll_ ( hapel llill.
`Mir-bun Rubinstein. The llehym l‘mh‘r‘ill" nl Jeiumlcm. le
`“€0th (‘zlrlilinii
`Wollgung Sldée. Uhiu Stale l'xiiicml). ('nliimliiis. Uliiu
`W. Mull Sullniul. ("time-ll Unnenm. llhuea. New \ urll
`Gulllm Radium. Ulll\‘L‘l',\ll) III LuniJuIi. l.\|1IkltIII. L niled Kingdiiiii
`.Inlin F. Carpenter. l'nnemty Iil (‘ulnrudii~ DemeL (‘oluriilln
`Wei-Chino: Shea. liniveim} nl Suulhern (‘aililliiniiL Lm Angela. 5
`Steven J. Shire. Licneiitceh. lIIL . 5. Sun l'niiieiueu. (frilllumia
`Alien H. l- Clio». l'hincsu l iineml) ul Hung lwng. Sliutin. Hung lwng
`Paolo Clillnllbo. L'nuersil) of Parmn. Pairmii. Iluli
`Kenneth B. Sloan. linii-crsily 0! Honda. (ininesiille. Florida
`Michael Colbo, Bristulfllyen \‘quibh. Hillside, Ne“ Jcm)
`build Ii. Small, L'nneniti t‘l Midi-gun, Aim Arboi. Michigan
`Petriell Couvretir. Unu emit: dc l'airia-Sud. ('lialuntii-Miilzihi). l’lallu.’
`Valentino 1. Stella. linii'erxily ol‘ Knnxm. l awn-nee Knnsui
`Hlflllllll Darentlnrl. l'nivenily nl Flundn t‘minesnlle. l-lur'idn
`Yuldii Sufiynm. Unnerx'll) at Tokyo. Tully). lnplin
`Rulli Duncan. ('iiidil'l' L'nlwixily, (’urdill, United Kingdum
`Sean Sulllvln. l‘iiixeml) Ul Florida. l'mlliesnlle l'luIldd
`Williun E. Evans. St. Jude‘s Children's Research Hospital. \lL‘tllplth. 'leiinexwe
`Ytidiitmbii ‘I‘altlllurn. K)nhl llniiemly. Kintn. .lLll‘llll'l
`Gary Fujil. 'Vlnleculiir I‘VPI'L'SS. lnc,. lm Angeles, l'ulifnrnin
`limo TIM-yum. l’lllhlll l‘III\I.‘l.\tl\. l'nltin. .lzipiiu
`Ho-Ixng Fling. SUNYB Sehwl (It Phuimaei. Anilieisi. Ne“ \‘ui‘L
`Tetsuyl Term-Iii.
`l'uh-Iku liniversili. Sendai. Jar-mi
`
`Sven I’mlljlr. Royal Dnnhh Schmil nl Pliiirm:
`(‘le'nhilgk‘IL Denmark
`Bern-rd Testii. llnivenll) nl LdllNill’IIIL'. Luuunnc. Suit/crlund
`Igor Gouda. Acrul. Mclhoume. .‘tuslinlm
`kennetll IIInInIm-l. l‘iiiiutsil) ul Washington. Scaltlc. “inning“!
`Margaret: Ilmulund-Udeauu. l'lllV‘rhllV ut L ppmla. “ppmlln. Sweden
`Allin Tuiji. Knnnmnn l7nti'crsil\. Knnnnmu. Japan
`In lenrtli. l'niien‘ili III Viiilhern ('tilifiirmn [m {\IlgClCS, (Iililnriiiii
`Arto llrtll. lWIlHu‘sll)‘ ul Kunpiu, Kunpm, Finliind
`Multini Haymhi. [okyti Unneisity ul Phurmnq & LIlL‘ Sue-nu». Tukyu, ,lnpdn
`Keiji Yum-nut". ('liihn l'nl\t.‘l\ll_\. (‘Iiihii .Inpnii
`Win E. Henninlt. lilieelil lnmulc lnr l’llufmilt‘cllllcdl Science-x l'lreehl. The
`BOOK REVIEW EDITOR
`Netherlands
`Kin-Ii I‘nrk. l'urdm; l'nixersiiy. Sent-n] nl I'harnme}. “est Li
`Sunni Ilenliemon. Aliigen lnet. Thuuslind (Lib. ('ulilnrnia
`J71“)?
`Aniline} .l. Illclte). l'nnemI) nf Vlirlh (‘Iimlmn rll f‘hapel l‘llll. ('linpel llill.
`Nnrlh (‘liruliiiu
`EDITORIAL ASS 'I‘AN'IS
`Rntli Ellis-Ballard
`Sung-Jim Huang. l'liuiignnni Nalmnnl l nncmiy, South kurL‘JI
`
`Eliuhetli II. (longunt
`T
`jl lg]. liniwnil) ill 'lvl'k)” llmpilnl. I'Iilt)“, Lipiiii
`lithe": llluui. West l'lIillllIttL’ttlJllL‘dl SUH‘IL‘L‘. Nntluiglium. l niled Kingdum
`l‘omoiui Urlliylui-
`
`\t‘ml-iiiIe'l‘II'iIiini I'iihluliru I’H It.“ t“_
`nun Mi
`|)t|ttltulll
`l'lu Nel
`In MINII
`iimiiilIli
`I’IIARMAI'IJV'I'II‘AL Ill-SEARCH INV‘. Off-I-A‘Jll i~ 'Iiililnlit-l
`sum-cumin" price I' \ siliwui «n [It iglii .unl "\illllllg h} l'uhlimluim l \pcillllllg. Im'
`.‘.II) Melu‘lum Menu.
`l liiioni. .N Y llllifi
`l'mudiul» [\tl‘lllgt. Nltl ll )nmuwmfl'
`Inimnliuml
`l‘hummu-umiil Rru'un Ii 1- dlhll-ll led m .Iitlentl in t'lieiiii...il Alkll’lith ( uni-m ( IIIIIL'IIINl Ile \t‘ieiitc l. MIL—\Sl 1|
`\LL'If‘ltl Medim llltlt’\ \lediein \Il l)l l\l
`
`\thmtis Mt-
`‘II I?
`' .
`Ltll
`llacunienhili-In \en-ite Rt‘lclrntt l'ridzile. Science I Ildlllm |ndt-\
`\eirnn (mill-iii
`lmleI
`I~\p.indeIl nml
`l'lie lSl Alrtllllg \enitew -
`( urpomlion. ‘10 [VIII \‘l lIii~ null; inn} N rel‘mdm‘ed. ‘llllCd in ii Ieliieiul nxicm uI Ir.iil~niiiletl III an} Inrm ur m um nit-4m. ulcelmnn meetinriieul. pliniucuriiine.mieru
`'
`
`m tlll'll mixer mlhnul uriilen permnstnii imm Il'h. Pllblbhcr. min the exeepimn oi .m_\ iii.iicii:il Wmlllcd \IK’L’IIIL’iIIlI In: the [\urpuie ul lwiiig eiileicd and executed on :i u
`eulusuu nu- l“ lhr pnielmwr ul [lie and I'Iiummu-uluul Rruun Ii p.iflitip.ile~ III llh ('npinglii (Immune: t ’eIIIer II 'I '('I li.in~,ielniii.il Reluirliiiy \cnitr llte Appeal!!! -
`i.
`
`In III; hulluni ml the I’mi [hiuc ni m lulu-l. m Ihu .nunul lndILJlL’fi Iht mmnym .mnu ~ elunsenl Il‘hil cupiu nI
`lhe .Irin-Ie mas h mud. Iur pews-until nr Iflll'llhll I!“ Ito-
`.“T Rllw“lihl [)nw Dunn-n,
`uii th t'illlLlIlltil’l that ill: nip [my .i
`|I.iI [lee [‘L‘I cup} pet .II’IIL’ll‘ mu -IlelllI|I\.Il pet page Ieesi duet-Ill In Ilil ('umiiglil lle.iI.im‘el rum I'll
`
`IilliLi Ivuun LII'I')n)‘lIlILl'ml. Im arming IIIIli.‘\I\lIC1ll\ penniiitd h_\ \‘telium lil‘ nr luh ml the l‘ 5 (upiriglil law Hie ('t ('i— .‘I iwnpmlil clemnehuuw In: lllL payment tit
`ltic
`iilw
`hm:
`(Iii-i uinscni di-ex n-II ulciid Iii ullieI Iiiid~ Ill eirliiiiie. «ugh as turning Iill ewlwul disluhul
`lee~ by “harm and ullIei uficn iegixiered min Ihe t
`t
`l‘
`
`pII-iiinliuiul I‘quMx Limiting new etillcclm. limb. or I-ii Iu~;ile. iiul In the repiiiiling ui Ileuin ”lilo. and It“! nu nth. UTLLK’JI I!)
`I\\l\df|l~ll\g Inqilinex \l’lt‘lllll he liddrened in :\tl‘crll~lng Stiles, I'lluniitln-nimil KI mm It. \lc'Velll ('liuup. lllL . WI (Mind \ .illei Rlldd. WK, \ ll'kllL‘). l'enlmluiiiii NWT
`Cl UNI) and In (2"! ,‘Il ‘Ifllh
`
`\quanu-n mquuiu .ind sulnuipinm urdrn stuml-l Ix .iddiem-tl III "R [llll‘lhllt'l .n Inllmu I m .1“ uilIIIIIIL‘~ unwinding ~iih~euplmn .ii-eiih in ‘uirih and l .itin kinericai'
`[)Nuhinmn ('t-iilu PUB-n ‘3: Hal) AH l)nrdreehl
`III: Nellierlandx tel
`1.]
`’H h‘7ti1illl
`l.i\ Kl
`'H M70474 L‘-I'I'|.i|ll nrderdeplumkqml
`I'iihli~lie r- J-iiiiiiit'h I )epm Imem
`
`nun-men iiiili
`in Nnrlh .Nnulh .imH eiilrnl America. kluiicr .\elidrmit l'iihlii-lirl\,1i~iiiiiu|~ IICPHIIIIIL‘III, Illl Philip Driie, -\.\~iilliipi Pail. N‘umulli M \ IIZMI
`l‘5l\, Id, I
`l 7.“ rm ”ll-HM; filtlll' kliineiwuklipmnu Sulheiipliim lulu
`Lil
`\ uluim W. 3m: l l.‘ mum I‘vmi III (‘lL‘xlIHllIL H R lli‘nl IiIi l ‘\H l mum l‘rInI .md elthiIIIiL’
`l
`l H I Illmi‘l ‘xli LIMP“ Imlnulimi \ilhnri'u’u turn-lung iimi lb:
`lam-ind ux (prinl unliI I
`l R Is'illll .Nl)
`lKTllI
`IIIIIXJ‘ITX
`LS. I’OSTM \h'l'l’lR: Send .iddlc» L'hJIIL'e“ In I'lnmuuiwmmf [\‘1 mm It Khmer Academicll'lt-iiiim Piililltlwis. 2'.“ Swing SiIeei New. \ lurk. N \
`l‘riiill d III the l \x\
`
`
`
`
`
`Page 2 of 11
`
`
`'
`
`—<
`
`
`
`

`

`PHARMACEUTICAL RESEARCH
`
`l ucial Journal of the American Association of Pharmaceutical Scientists
`
`
`
`‘ 19 Number 2
`
`
`
`CONTENTS
`
`February 2002
`
`’ CH PAPERS
`
`.1
`
`.ting
`
`,'
`
`
`
`
`-- of the Structure of Drug Moieties on the in Virm Efficacy of HPMA Copolymer-Geldanamycin
`Derivative Conjugates
`1""iKasuya. Zheng-Rong Lu. Pavia Koper‘km'a'. S. Esmail Tahihi, and Jindfieh Kopec’ek
`
`
`1!
`
`termination of Binding of Cisplatin to DNA in the Presence of Biological Thiols: Implications
`of Dominant Platinum-Thiol Binding to Its Anticancer Action
`: Volckovu. Lea P. Dadones, and Ralhindra N. Bose
`
`
`
`
`. ndency of DL-Lactide/Glycolidc Copolymcr Particulales for lntra-Articular Delivery System
`on Phagocytosis in Rat Synovium
`Ufra Harirawa, Kalsaaki Kubom. Izumi Tubal, Keiichi Sara. Hiromirsa Yamamoro.
`11‘ :fumi Takeuehi. and Yoshiuki Kawashima
`
`
`
`
`
`
`
`
`m traaki Nakamaru, Fumihikn Ushigome, Nnrikn Knyahu. Sim/i Samh, Kiynmi Tsukinmri,
`.' uooNakano. Hisakazu Ohmni. and Yasufimri Sawada
`
`-;-ili1y Profiles of M-Alkoxysubstituted Pyrrolidinoethylesters of Phenylcarbamic Acid across
`Caco—2 Monolayers and Human Skin
`" , 1 ka Gyiirfisiovd, Leena Lailinen. Johanna Rairmm. Jozef Ciz'nuirik. Eva Sell/dram. and
`'auni Hinl'onen
`
`“1 : Processing of Poly(Ethylene 1mine)/Ribozyme Complexes Can Be Observed in Living
`Cells Using Confocal Laser Scanning Microscopy and Inhibitor Experiments
`I Merdan. Klaus Kalmlh. Dagmar Fischer. lindrich Knpecek. and Thomas Kissel
`
`-
`
`_
`
`3‘
`
`i.|ll1
`
`'tive Inhibitory Effects of Different Compounds on Rat Oatpl
`(SlethLil-Mediated Transport
`=1 oshihisa Shiram. Daisuke Sugiyama. Himyaki Kusuhara. Yukiu Karo. Takaaki Abe.
`_" er]. Meier. Tommi huh. and Yuiehi Sugiyuma
`
`(Slc21al)- and 021th
`
`'- Gradient~Dependent Transport of Valproic Acid in Human Placental Brush-Border Membrane
`Vesicles
`
`
`
`‘~ ntial of Chitosan in Enhancing Peptide and Protein Absorption across the 'l‘R146 Cell
`Culture Model-An in Vim: Model of the Buccal Epithelium
`I Porrero. Carmen Remarizin-Lépez. and Hanne Merck Nielsen
`
`
`
`
`
`NW»
`
`, Acylation by Poly(a-H_vdroxy Esters)
`rea Lucke. Josef Kiermaier. and Aehim (iopferieh
`
`Page 3 of 11
`
`115
`
`124
`
`140
`
`147
`
`154
`
`162
`
`169
`
`175
`
`

`

`
`
`CONTENTS (Continued)
`
`Experimental and Computational Screening Models for Prediction of Aqueous Drug Solubility
`Christel A. S. Bergstrom, UlfNorinder, Kristina Luthman, and Per Artursson
`
`
`
`
`Pharmaceutical Engineering
`
`Production and Characterization of a budesonide Nanosuspension for Pulmonary Administration
`Claudia Jacobs and Rainer Helmur Muller
`
`Thermophysical Properties of Phannaceutically Compatible Buffers at Sub-Zero Temperatures: Implications
`for Freeze-Drying
`Evgenyi Y. Shalaev, Tiffany D. Johnson-Elton, Liuquan Chang, and Michael]. Pikal
`
`PharmacokinetieslPhu-macodynamics
`
`Effect of Testosterone Suppression on the Pharmacokinetics of a Potent GnRI-I Receptor Antagonist
`Eugenia A. latsimirskaia, Margaret L. Gregory, Kenna L. Anderes, Rosemary Castillo.
`K. Eric Milgram, David R. Luthin, Ved P. Pathak, Lance C. Christie. Haresh Vazir.
`Mark B. Anderson, and John M. May
`
`Ignoring Pharmacokinetics May Lead to Isoboles Misinterpretation: Illustration with the Norfloxacin~
`Theophylline Convulsant Interaction in Rats
`Miren Cadart. Sandrine Marchand, Claudine Pariat. Serge Bouquet. and William Coue!
`
`AAPS ELECTRONIC SCIENTIST
`
`Debbie Werfel
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Page 4 of 11
`
`

`

`
`
`mtucnuiml Research.
`
`l"nl. I9, No. .7. Fehrmln' 3002 RD 2002)
`
`Research Paper
`
`
`
`ermophysical Properties of
`harmaceutically Compatible Buffers
`
`. Sub-Zero Temperatures:
`... plications for Freeze-Drying
`
`
`'
`
`_ nyi Y. Shalaev”. Tiffany D. Johnson-Elton".
`. uan Chang‘. and Michael J. ritualJ
`
`veil October 10. 200i; accepted November I. .7001
`
`. To evaluate crystallization behavior and collapse tempera-
`I
`.
`ng') of buffers in the frozen state. in view of its Importance in
`
`development of lyophilized formulations.
`
`'
`v
`v
`I
`Sodium tartrate. sodium malate. potassium citrate. and so-
`u citrate buffers were prepared with 3 pl! range within their
`
`-' ‘dual buffering capacities. Crystallization and the Tg‘ were de.
`‘
`I during healing of the frozen solutions using standard DSC‘ and
`-n led DSC.
`
`
`i
`Ls. Citrate and mobile did not exhibit crystnllizution. while suc-
`. e and tartrate crystallized during heating of the frozen solutions.
`
`citrate buffer had a higher Tg‘ than malatc and tartrate buffers at
`
`same pH. Tg' vs. pH graphs for citrate and malate buffers studied
`. a similar shape. with a maximum in Tg‘ at pH ranging from 3 to
`
`- Tg' maximum was explained as a result of n competition
`
`- a two opposing trends: an increase in the viscosity of the armor
`.
`~ phase because of an increase in electrostatic interaction. and a
`
`u
`in the 'l'g‘ because of an increase in a water concentration of
`freeze-concentrated solution.
`
`~
`‘ damn. Citrate buffer was identified as the preferred buffer for
`
`.-' ’ ed pharmaceuticals because of its higher 'l’g' and it lower
`
`-
`ization tendency.
`
`t WORDS: lyophilimtton; freezing; hul'lers; collapse: glass Iran-
`-
`'DSC.
`
`' ODUCI‘ION
`
`
`
`Many pharmaceuticals contain a buffer to control pH. to
`n ' optimal chemical and physical stability of a drug mol-
`. Buffering capacity and a possibility of a buffer-specific
`‘
`
`is are the major buffer properties which are usually
`‘1')
`into consideration in development of liquid pharma-
`'-:
`
`I'l fonnulations (I). For lyophilized formulations. there
`No additional physical chemical parameters to consider.
`
`buffer crystallization potential at sub-ambient tempera—
`
`- and the collapse temperature. A buffer component may
`
`.V‘ ' ' during freezing producing significant pH changes
`
`':, tare usually undesirable and should be avoided. Crys-
`lion and pH changes of phosphate buffer at suhvzero
`
`’
`tures were studied in detail in the presence of differ—
`wetal ions and in a wide range of pH and concentration
`
`3 Systematic studies of equilibrium freezing behavior of
`
`
`
`. m Laboratories. Pfizer Inc.. Groton. Connecticut 06340.
`
`.. of Pharmacy. University of Minnesota. Minnesota.
`
`.
`i of Pharmacy. University of Connecticut. Sturrs. Connecticut
`
`Rhom correspondence should be addressed.
`
`‘_y,shalaevtg'grotonplizencom)
`
`te-mnil:
`
`in
`phosphate buffer were performed by van den Berg 6! ill.
`1950—1960. In these studies. liquid (unfrozen) portions of a
`frozen solution was physically separated at sub-zero tempera-
`tures. and the pll and composition of the liquid portion were
`measured at room temperature (2—4). Later. other methods
`were used such as measurements of pH at sub-zero tempera-
`tures with a low-temperature electrode (5.6.8.9) and pH in-
`dicators (10). X—ray diffraction measurements at sub-ambient
`temperatures (7). and DSC studies (ll-13). Significant pH
`changes were observed depending on a metal ion type and
`experiment setup (sample size. cooling rate). Based on these
`results. phosphate buffer is generally regarded to be undesir-
`able for lyophilized formulations. at least if high buffer con-
`centrations are required to maintain high buffer capacity ( l4).
`There are some studies of other buffers of pharmaceutical
`interest (citrate. glycine. succinate. carbonate) in very narrow
`ranges of solution pH and concentration (9.l0.15).
`Another physical chemical parameter critical for lyophi-
`limtion is the collapse temperature (16). Freeze drying above
`the collapse temperature produces loss of the cake-like struc-
`ture that one desires. Obviously. materials with a higher col~
`lapse temperature can be freeze dried at a higher tempera
`ture. hence providing a faster and more robust lyophilization
`cycle. If the collapse temperature ofa formulation is relatively
`low. it is more difficult and sometimes impossible to lyophilize
`such a fomiulation in a practical process. As a rule. presence
`of amorphous buffer in a formulation decreases the collapse
`temperature resulting in recommendations to minimize buffer
`concentration in lyophilized formulations (l7). The collapse
`temperature can be measured by different techniques. with
`freeze drying microscopy and DSC being the methods of
`choice in most cases. With DSC. a thermal transition denoted
`
`Tg~ is measured as the temperature of an endothermic step
`which precedes the melting endotherm on DSC heating
`curves of frozen solutions (Io).
`It should be stressed that
`interpretation of the physical nature of the Tg‘ thermal event
`is still controversial. There are two alternative interpretation
`of the Tg'. The Tg‘ thermal event has been explained as either
`a glass transition of the freeze-concentrated solution (18.19),
`or onset of ice melting marked as Ts (softening temperature)
`(20). or Tm (21). Despite of this controversy. there is a com-
`mon agreement that the 'Tg‘ corresponds closely to the col-
`lapse temperature. the collapse temperature normally being
`higher by l-3°C (16). Frequently. one detects a second very
`weak apparent glass transition roughly 20“C lower than Tg'.
`This lower transition is denoted Tg“. and does not appear to
`be related to the collapse phenomena. The Tg' of several
`acids and bases (ascorbic acid. citric acid. glycine. HEPES.
`TRIS) and buffers (citrate. TRIS. acetate. glycine. and Mati-
`dine) has been determined in (12.15.22-25).
`ln majority of
`these studies. the Tg' was determined at a single pH value
`(with exceptions (25) for histidinc and ( l5) for glycine). There
`is a lack of systematic data on collapse temperatures and
`crystallization behavior as a function of pH for buffers of
`pharmaceutical significance.
`In the present study. crystallization behavior and col-
`lapse temperature of several buffers (citrate. succinate. ma-
`late. tartrate) have been studied using DSC. Each buffer was
`prepared at different pH to cover the buffering range of the
`particular buffer. It should be emphasized that variation of
`
`
`
`Page 5 of 11
`
`195
`
`lr‘:-‘-f‘74l.‘il='lllfll<lll"5"“ V" :lKl.’ Plenum Publishing (foil-motion
`
`

`

`I96
`
`Shnlacv. Johnson-Elton. Chang. and Pin
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`§E 5L
`
`L 5OI
`
`§5 E E:
`
`t:
`
`40
`
`-20
`
`Temperature (°C)
`Fig. I. Representative DSC healing curves of citric acid/Nat‘m (A)
`and citric acid/KOH (B) solutions. Magnified low—temperature porv
`tions of the DSC scans are shown. Numbers present solution pH.
`Scanning rates: It)"'(‘lmin. The experiments were run with Prrkin'
`Elmer Pyris-l DSC.
`
`cndothcrm is not shown). Two consecutive endothermic
`events. Tg" and Tg'. were observed in majority of cases which
`is typical for frozen aqueous solutions (18-21). There is a
`common agreement that a higher temperature event (Tg')
`corresponds to the collapse temperature.
`A "clip“ in the baseline was observed on DSC heatina
`curves of sodium citrate at pH's from S to 7. Such "dip" on I
`DSC heating curve could be due to an exothermic event sudl
`as crystallization; if this is the case. assignment of the TB.
`event is uncertain. To determine if crystallization occurred in
`these samples.
`two types of DSC experiments were [369
`formed. In the first experiment. a thermal cycling study “’35
`performed; thermal cycling allows one to separate reversiblfi
`thermal transitions (such as glass transition and melting) from
`irreversible transitions (such as crystallization) and artifacf‘
`(such an event associated with a change in a sample shape a
`the DSC pan) (20.26). In this thermal cycling experiment. “I"
`frozen solution was first heated to «145°C (which is the Uni“
`temperature of the thermal event under consideration) f0"
`lowed by cooling to —65‘C. and then heated from —65 to 25°C
`If the thermal event under consideration is the (ice) rrySml‘
`lization exothenn. the second DSC heating curve should hit“
`a different appearance because crystallization would 0‘79“"
`only during the first run and thus would be irreversible. 1"
`particular. the temperature of the first endothermic 51"
`would be shifted to higher temperature (if ice crystalli/c‘l 0‘
`to the lower temperature (if solute crystallizes). Results Of
`thermal cycling experiment are shown in Fig.2u. It can M 5
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`pH is equivalent to variation of the molecular/ionic species in
`solution as pH variations alters the extent of ionization of
`buffer. Significant changes in the crystallization behavior. and
`the Tg‘ were observed as a function of solution pH. An un-
`expected pattern of Tg‘ changes with solution pH was ob»
`served for all buffers studied with Tg‘ having a maximum
`:tround pH 4. In addition. it appeared that a metal ion type
`(i.e.. Na vs. K) has a significant impact on Tg‘ of a citrate
`buffer.
`
`MATERIALS AND METHODS.
`
`Materials
`
`Reagent grade succinic acid and DL-malic acid were pur-
`chased from Fisher Scientific and Sigma. respectively. Citric
`acid of USP grade. L-(+)-tartaric acid of NF grade. and so»
`dium hydroxide of NF grade were obtained from JT Baker. In
`addition. DL-tartaric acid of reagent grade from EM Science
`was used. Dcionized water was used to prepare all of the
`buffer solutions that were studied. Citric acid. succinic acid.
`
`tartaric acid. malic acid were prepared as 0.25M solutions.
`The acids were titrated with 0.25M sodium hydroxide to the
`desired buffer pll. In addition. citric acid/potassium hydrox-
`idc solutions were prepared by the same methods. Weight of
`the added base was measured. The pH range studied was
`chosen as to be within the pH range where the buffer system
`had significant buffering capacity (1).
`
`DSC Experiments
`
`DSC experiments were performed with a Perkin-Elmer
`Pyris l instrument and TA Instruments modulated DSC 2920
`instrument equipped with Refrigerated Cooling System. Ap-
`prox. 15 pl of solution were placed in aluminum pans. and
`empty aluminum pans were used as a reference with both
`instruments. Other details of the experiments performed with
`the Perkin-Elmer instrument are as follows. The instrument
`
`was calibrated using melting points of indium at heating rate
`10°C/min. The calibration was checked using de-ionized wa-
`ter. The uncertainty in the temperature calibration was esti~
`mated to be within 1.5’C. Samples were cooled to -6(l°(‘ at
`10°Clmin. then held at —60°C for 5 min. and then heated from
`430°C to 25"(‘ at ”PC1min. The Tg‘ and Tg" temperatures
`were dctcmtined as extrapolated onset temperatures using
`Pyris software. Experiments were performed with the TA
`instrument as follows. Calibrations were performed using in-
`dium as standard at a heating rate NFC/min and l"'(‘/min for
`standard and modulated method. respectively. The purge gas
`used was nitrogen with a flow rate at 50 ml/min. Samples were
`run in two different modes: (i) Standard DSC mode. which
`the samples were cooled to -60"’C at 10"C/min. cquilibrate at
`-6()“C for 5 min. and then heated to 25°C at UPC/min. (ii)
`Modulated DSC mode. which the samples were cooled to
`—6(l°C and then heated to 25°C at the same heating and coolv
`ing rate of 1”C/min. The run was modulated with an ampli-
`tude xtlj‘C and a period 100 seconds. The Tg‘ and Tg" tem—
`peratures were determined as extrapolated onset tempera—
`tures using TA universal analysis software.
`
`RESULTS
`
`Typical DSC curves of sodium and potassium citrate
`buffer are shown in Figs. la and lb. respectively (ice melting
`
`% P
`
`age 6 of 11
`
`

`

`
`
`.
`
`i ophysical Properties of Buffers at Sub-Zero Temperatures
`
`197
`
`
`
`-3o
`
`8 4o
`
`
`s
`Temparature(°C) is8
`
`-50
`
`430
`
`2
`
`3
`
`4
`
`5
`
`s
`
`7
`
`Solution pH
`
`22(
`
`U-
`
`a g
`
`l-
`
`Solution pH
`Fig. 3. Tg‘ and Tg" of citric acid/NaOH (A) and citric acid/KOH (B)
`
`solutions as u function of pH. C: Tg' measured with 'l'A DSC: I: Tg'
`measured with Perkin-Elmer DSC: l3: Tg" measured with TA DSC;
`O: Tg" measured with PerkinvElmer DSC: A: Tg‘ measured with TA
`MDSC; V: Tg“ measured with TA DSC: O: Tg' measured with TA
`DSC in themal cycling experiment: X: Tg" measured with TA DSC
`in thermal cycling experiment. Each data point corresponds to a
`single DSC run. Lines are given as an visual aid.
`
`different sample preparations. For sodium citrate. hoth Tg'
`and Tg“ passed through a maximum at pH ~4. Similarly. for
`potassium citrate. Tg' passed through maximum between pH
`3 and 4.
`DSC curves of malic acid/NaOH solutions had a similar
`appearance to the citrate buffer solutions with one or two
`endothermic steps (Tg" and Tg') followed by ice melting peak
`(curves are not shown). Tg" and Tg' of malate buffer as a
`function of solution pH are shown in Fig. 43. Again, Tg' goes
`through a maximum at pH 4.
`Succinic acid/NaOH and tartaric acid/NaOH solutions
`
`demonstrated a different thermal behavior. Representative
`DSC heating curves of succinic acid/NaOH and tartaric acid/
`NaOH systems are shown in Figs. 5 and 6. respectively. Buffer
`crystallization occurred in all three succinic acid/NaOH mix-
`tures studied (pH 4. 5. 6) as evidenced from observation of
`both the exothermic peak (D) and endothermic peaks (M)
`prior to ice melting. A weak endothermic step immediately
`before the crystallization cxotherm. which was observed at
`pH 5 and 6 in succinatc buffer (Fig. 5. inset). may be assigned
`to either Tg' or Tg". We did not attempt to characterize this
`transition in more detail. Crystallization was not detected in
`pure succinic acid. Lack of crystallization observed for the
`free acid indicates that a salt (not the free acid) crystallized
`during heating of frozen succinic acid/NaOH solutions. In
`
`
`
`
`
`
`Temperature (°C)
`Thermal cycling (A) and modulated DSC (B) runs of citric
`‘ 80H solution with pH 6. The data were obtained with TA
`
`)
`
`first and second healing curves are practically identical.
`1 e position of the first endothermic step did not change
`. second scan. Hence. the results of the themial cycling
`ent suggested that crystallization did not occur during
`
`
`
`
`
`Modulated DSC allows separation of irreversible
`- as crystallization) and reversible (such as glass transi-
`
`Ihermal events (19). Modulated DSC heating curves are
`.v
`in Fig. 2b. The reversing heat flow curve shows two
`tive endothermic events Hg" and Tg'). similar to a
`
`DSC scan. The nonreversing heat flow curve shows
`
`re is perhaps some crystallization. as evident from the
`exothermic peak centered at -45"‘C: however the mag-
`- of the exotherm is very small. and the modulated DSC
`' Ie not consistent with a significant amount of crystalli-
`.‘ occurring during heating the frozen solution. Tg‘ tem-
`.
`- e determined from the modulated DSC run is slightly
`
`' than determined from the regular DSC scan: however.
`
`“i rence is close to the estimated experimental error.
`ventral cycling and modulated DSC experiments indi-
`l“ t regular (non-modulated) DSC scans can be used to
`
`Tg' and Tg" of the sodium citrate solutions at pH 5
`"' e did not attempt to investigate the origin of the ap-
`
`' “dip“ which was observed prior to the Tg' event for
`I
`-- citrate solutions at pH 5 to 7 in more detail. Figure 3
`
`Tg' and Tg" as a function of pH for sodium citrate and
`
`‘ m citrate. There is good agreement between results
`i with the two different DSC instruments and with
`
`'
`
`
`
`
`
`
`Page 7 of 11
`
`

`

`198
`
`Shalaev. Johnson-Elton. Chung, and Film
`
`3
`
`4
`
`5
`
`6
`
`(°C)
`Temperature
`
`
`
`
`aTemperature(°C) isU)
`
`‘6
`
`a
`
`4
`
`5
`
`Solution pH
`
`Fig, 4, Tg' and 'l'g" of malic acid/NaOH (A) and tartaric acid/NaOH
`(B) solutions as a function of pH. All data point but open squares in
`Fig. 4B correspond to solutions prepared with L-(~»)-tartaric acid. and
`open squares correspond to solutions prepared with DL-tartaric acid.
`See Fig. 3 for other symbols. Each data point corresponds to a single
`DSC run. Lines are given as a visual aid
`
`agreement with this hypothesis. both crystallization exo-
`thcmis and melting endothem'is were stronger in succinate
`solution with pH 6 (solution with a higher salt content). In
`addition. multiple melting peaks were observed at pH 4 and 5.
`indicating that several crystalline succinate salts were formed
`(i.e.. perhaps mono- and di-sodium succinate and their by-
`dratcs).
`A Tg‘ event followed by a strong crystallization peak was
`Observed in a solution of L-(+)-tartaric acid/NaOH at pH 3
`(Fig. (in). In addition. a weaker exotherm was observed in
`solution of pH 4. We note that a solution of DL—tartaric acid/
`NaOH at pH 3 had a much weaker exothermic event (scan is
`not shown) indicating that the racemic reagent had a lower
`crystallization tendency. Fig. 4b shows Tg' and Tg" vs. pH for
`tartaric acid/NaOH system. Despite of the difference in crys-
`tallization behavior. there was no significant difference in the
`Tg' between solutions prepared with either L-(+)-tartaric acid
`or DL.-tartaric acid. Both Tg' and Tg" for tartaric acid/NaOH
`solutions were slightly higher at more acidic pH (pH 3) than
`at pH 5.
`
`DISCUSSION
`
`Tg‘ vs. pH profiles with a maximum were observed for
`citrate and malate buffers. Such behavior has not been re-
`ported in the literature. The lack of literature precedent is not
`
`Page 8 of 11
`
`Heat
`
`Flow(mW)
`
`Temperature (°C)
`Fig. 5. Representative DSC heating curves of suoeinic acidifs'nOH
`solutions. lnsct shows magnified portions of DSC curves with :i non-
`idcntilicd thermal event (which may be either Tg' or Tg"). Scanning
`rates: l0”Ca'min.
`
`surprising. Indeed. there is only one systematic study of Tg'
`vs. pH described in the literature (25). It was observed that
`Tg' of frozen histidine solutions decreased with an increase in
`pH (25). Such a decrease in 'l‘g‘ was explained as due to
`increased salt concentration.
`
`in this work. an opposite trend in Tg‘ vs. pH was ob-
`served. i.e., Tg' first increased with increasing salt concenm'
`tion. To illustrate this point. Tg‘ is presented as a function of
`NaOHJcitric acid mole ratio (Fig. 7). An increase in sodium
`content initially produced a significant increase in Tg’ (Which
`is opposite to the trend reported in (25) for histidincl. fol-
`lowed by a gradual decrease in Tg‘ with further increase in
`sodium content.
`
`An increase in Tg‘ with increasing sodium content can be
`rationalized in terms of increasing ionic interactions .1» the
`concentration of ionic species increases. Indeed. salts fre'
`quently have higher glass transition temperatures than the
`corresponding free acids. For the organic acid. indomclhaciflv
`Tg of the free acid was ~75"C lower than that of the sodium
`salt (27). Hence. the initial increase in Tg' in citrate and ma-
`late buffers when pH increased from 2.5 to 4 can be explained
`on the same basis. That is, ionization allows electrostatic ifl'
`leractions between species and corresponding higher viscos'
`ity. However. this "electrostatic interaction" concept ulonc
`cannot account for the maximum of Tg' vs. pH. Clearly Bn'
`other effect must be important

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket